Company chart and information is provided by TradingView based on 15-minute-delayed data.
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, engaged in developing anti-cancer drugs. It has two clinical staged drug development candidates and an early stage discovery program.
| Website: | www.novogen.com |
| Email: | investment.consultant@novogen.com |
| Main Phone: | +61 294724101 |
| Address: | 300 Barangaroo Avenue |
| Address 2: | Level 24 |
| State: | NSW |
| City / Town: | Sydney |
| Country: | AUS |
| Postal Code: | 2000 |
| Exchange: | NSC |
| CEO: | James Garner |
| Employees: | 16 |
| Issuer Type: | CS - Common Stock |
| Sector/Industry: | Healthcare |
| Last Price N/A | Change $ N/A | Change % N/A | Tick N/A |
| Bid N/A | Bid Size N/A | Ask N/A | Ask Size N/A |
| Open N/A | High N/A | Low N/A | Prev Close N/A |
| Last Trade | Volume N/A | 52 Wk Hi N/A | 52 Wk Low N/A |
| Market Cap N/A | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares N/A | EPS (TTM) N/A | PE Ratio N/A | Exchange N/A |
© 2022 Equities News | Equities.com, Inc.
* All dates and time are being displayed in Eastern Standard Time (EST).
